Nonradioactive fluorescence microtiter plate assay monitoring aptamer selections

BioTechniques

Volumn 42, Issue 5, 2007, Pages 578-582

  Wochner, Aniela ^a,b   Glökler, Jörn ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b RiNA GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DNA; FLUORESCENT DYE; NUCLEIC ACID; SINGLE STRANDED DNA;

AMINO ACID SEQUENCE; ARTICLE; BIOTINYLATION; DNA SEQUENCE; FLUORESCENCE ANALYSIS; GENE TARGETING; INCUBATION TIME; MICROTITER PLATE ASSAY; MOLECULAR RECOGNITION; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; ROOM TEMPERATURE;

APTAMERS, NUCLEOTIDE; BIOTINYLATION; CALIBRATION; DNA, SINGLE-STRANDED; FLUORESCENCE; FLUORESCENT DYES; SELEX APTAMER TECHNIQUE; SPECTROMETRY, FLUORESCENCE;

EID: 34250651356     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112472     Document Type: Article

References (15)

1. Ellington, A.D. and J.W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822.
2. Tuerk, C. and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510.
3. Rimmele, M. 2003. Nucleic acid aptamers as tools and drugs: recent developments. ChemBioChem 4:963-971.
4. Clark, S.L. and V.T. Remcho. 2002. Aptamers as analytical reagents. Electrophoresis 23:1335-1340.
5. Tombelli, S., M. Minunni, and M. Mascini. 2005. Analytical applications of aptamers. Biosens. Bioelectron. 20:2424-2434.
6. O'Sullivan, C.K. 2002. Aptasensors - the future of biosensing? Anal. Bioanal. Chem. 372:44-48.
7. Deng, Q., I. German, D. Buchanan, and R.T. Kennedy. 2001. Retention and separation of adenosine and analogues by affinity chromatography with an aptamer stationary phase. Anal. Chem. 73:5415-5421.
8. German, I., D.D. Buchanan, and R.T. Kennedy. 1998. Aptamers as ligands in affinity probe capillary electrophoresis. Anal. Chem. 70:4540-4545.
9. Ng, E.W., D.T. Shima, P. Calias, E.T. Cunningham, Jr., D.R. Guyer, and A.P. Adamis. 2006. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5:123-132.
10. Rimmele, M. and D. Orgel. 2004. Use of an analysing substance for detecting an explosive. WO 2004/024948 A1.
11. Menger, M., J. Glökler, and M. Rimmele. 2006. Application of aptamers in therapeutics and for small-molecule detection, p. 359-373. In V.A. Erdmann, J. Barciszewski, and J. Brosius (Ed.), Handbook of Experimental Pharmacology. RNA Towards Medicine. Springer, Berlin.
12. Stoltenburg, R., C. Reinemann, and B. Strehlitz. 2005. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem. 383:83-91.
13. Nutiu, R. and Y. Li. 2004. Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling. Chemistry (Easton) 10:1868-1876.
14. Gray, G.D. and E. Wickstrom. 1997. Rapid measurement of modified oligonucleotide levels in plasma samples with a fluorophore specific for single-stranded DNA. Antisense Nucleic Acid Drug Dev. 7:133-140.
15. Jones, L.J., S.T. Yue, C.Y. Cheung, and V.L. Singer. 1998. RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization. Anal. Biochem. 265:368-374.